WebMar 3, 2024 · DermTech, Inc. ("DermTech" or the "Company"), a leader in precision dermatology enabled by a non-invasive skin genomics platform, today announced that management is scheduled to present at the... WebMar 15, 2024 · This press release includes “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. …
DermTech Announces Release Date for First-quarter 2024 Financial ...
WebMar 15, 2024 · This press release includes “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. The expectations, estimates, and projections of DermTech may differ from its actual results and consequently, you should not rely on these forward-looking statements as ... WebMar 3, 2024 · DermTech is a leading genomics company in dermatology and is creating a new category of medicine, precision dermatology, enabled by its non-invasive skin … cycloplegics and mydriatics
DermTech Reports Third-Quarter 2024 Financial Results
WebOct 13, 2024 · In advance of the call on November 3, 2024, DermTech will issue its third-quarter 2024 earnings press release. For participants interested in asking questions during the teleconference, please ... WebApr 11, 2024 · DermTech, Inc. (NASDAQ: DMTK) (“DermTech” or the “Company”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, today announced an agreement with a Blues plan in North Carolina. The contract, which is in addition to a favorable coverage policy that became effective March 15, 2024, enhances … WebMar 2, 2024 · DermTech, Inc. (NASDAQ: DMTK) (“DermTech” or the “Company”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, today reported its fourth-quarter and full-year 2024 financial results. cyclopithecus